This inventor holds 1 USPTO granted patent and 4 EPO patents. Top assignee: Shanghai Microport Cardioflow Medtech Co., Ltd.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations of Jiaoming Dong in Bioprothesis Technology
Introduction
Jiaoming Dong is a notable inventor based in Shanghai, China. He has made significant contributions to the field of bioprothesis through his innovative research and development. His work focuses on creating advanced materials that can be used in medical applications, particularly in tissue engineering.
Latest Patents
Jiaoming Dong holds a patent for a "Dry animal-derived collagen fiber tissue material and preparation method and bioprothesis thereof." This patent describes a preparation method that includes several steps: rinsing an animal-derived collagen fiber tissue material treated with a crosslinking agent, immersing it in a non-aqueous alcoholic solution for dehydration, and then subjecting it to gradient dehydration using saccharide solutions. The final steps involve drying the tissue material and hermetically packaging it for sterilization. This method is notable for its simplicity and cost-effectiveness, utilizing readily available materials while minimizing toxicity from crosslinking agents. The resulting biological tissue material is pliable, tough, and exhibits better biocompatibility.
Career Highlights
Jiaoming Dong is currently associated with Shanghai Microport Cardioflow Medtech Co., Ltd. His work at this company emphasizes the development of innovative medical technologies that enhance patient care and treatment outcomes. His expertise in collagen-based materials has positioned him as a key figure in the advancement of bioprothesis.
Collaborations
Jiaoming Dong collaborates with talented professionals in his field, including Yemeng Chen and Guanbiao Xu. These collaborations foster a dynamic environment for innovation and research, contributing to the success of their projects.
Conclusion
Jiaoming Dong's contributions to bioprothesis technology through his innovative patent and work at Shanghai Microport Cardioflow Medtech Co., Ltd. highlight his role as a leading inventor in the field. His advancements in collagen fiber tissue materials are paving the way for improved medical applications and patient outcomes.